Article info
PDFClinical Pharmacy
CP-017 Incidence of neutropenia due to the use of peginterferon alpha 2a/2b during the treatment for chronic hepatitis C infection (VHC)
Citation
CP-017 Incidence of neutropenia due to the use of peginterferon alpha 2a/2b during the treatment for chronic hepatitis C infection (VHC)
Publication history
- First published February 24, 2014.
Online issue publication
September 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2014, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions